SCHEMBL4267780

SCHEMBL4267780

CCCCOC(=O)N1CCCC1COS(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HCRTR2 O43614 2/20 0.37
GBA2 Q9HCG7 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
RAB9A P51151 1/20 0.35
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 3/20 0.33
TP53 P04637 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18988227 0.92 LMNA (0.41) POLBLMNASMN1; SMN2HCRTR2GBA2
SCHEMBL14144107 0.83 POLB (0.45) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL5250880 0.82 POLB (0.44) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL5250883 0.82 POLB (0.44) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL3982504 0.82 POLB (0.53) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL1982237 0.82 POLB (0.53) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL6207733 0.82 POLB (0.53) POLBLMNASMN1; SMN2GBA2L3MBTL1
SCHEMBL18497662 0.81 LMNA (0.44) LMNAL3MBTL1RAB9AALDH1A1GAA
SCHEMBL1439521 0.81 LMNA (0.49) POLBLMNASMN1; SMN2GBA2RAB9A
SCHEMBL7563929 0.81 POLB (0.43) POLBLMNASMN1; SMN2GBA2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035372-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-03-18 EP disclosed
WO-2008005338-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-01-10 WO disclosed